Mirae Asset Global ETFs Holdings’s Minerva Neurosciences NERV Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio NERV Stock Details NERV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$87K	Buy	+15,678	New	+$85K	﹤0.01%	2890

Other funds holding NERV

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ABG

Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return

FCMV

Foresite Capital Management VI Larkspur, California $643M AUM 343.43% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Mirae Asset Global ETFs Holdings's NERV Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings opened a new position in Minerva Neurosciences (NERV) in Q2 2026: 15,678 shares worth $87K. The stake represents ﹤0.01% of the portfolio and ranks #2890 among its holdings.

60 funds tracked by Wall St. Rank hold NERV as of Q2 2026.

Mirae Asset Global ETFs Holdings held 15,678 shares of Minerva Neurosciences worth $87K as of Q2 2026.
Minerva Neurosciences was a new Mirae Asset Global ETFs Holdings position in Q2 2026.
Minerva Neurosciences made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2890 holding.
60 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.